CAS: 1310726-60-3 - Upadacitinib
Formula:C17H19F3N6O
InChI:InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1
InChI key:InChIKey=WYQFJHHDOKWSHR-MNOVXSKESA-N
SMILES:O=C(NCC(F)(F)F)N1CC(C2=CN=C3C=NC=4NC=CC4N32)C(C1)CC
Upadacitinib
CAS:1310726-60-3
Formula:
C17H19F3N6O
Purity:
99%
Color and Shape:
Solid
Molecular weight:
380.3676
Ref: IN-DA01E0UI
1g | 154.00 € | ||
5g | 520.00 € | ||
10mg | 51.00 € | ||
25mg | 50.00 € | ||
50mg | 61.00 € | ||
100mg | 77.00 € | ||
250mg | 113.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Upadacitinib
CAS:1310726-60-3
Formula:
C17H19F3N6O
Color and Shape:
Off-White Solid
Molecular weight:
380.38
Ref: 4Z-U-103001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-U-103020
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Upadacitinib
CAS:1310726-60-3
Upadacitinib (ABT-494), a selective JAK1 inhibitor, is researched for autoimmune diseases; IC50: 43 nM.
Formula:
C17H19F3N6O
Purity:
99.41% - 99.93%
Color and Shape:
Solid
Molecular weight:
380.37
Ref: TM-T7503
1mg | 46.00 € | ||
2mg | 61.00 € | ||
5mg | 88.00 € | ||
10mg | 127.00 € | ||
25mg | 217.00 € | ||
50mg | 302.00 € | ||
100mg | 427.00 € | ||
200mg | 650.00 € | ||
500mg | 1,142.00 € | ||
1mL*10mM (DMSO) | 49.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
Ref: 4Z-U-103021
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 13 Dec 2024
Ref: 4Z-U-103002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 13 Dec 2024
ABT 494
CAS:1310726-60-3
Inhibitor of Janus kinase JAK-1
Formula:
C17H19F3N6O
Purity:
Min. 95%
Molecular weight:
380.37 g/mol
Ref: 3D-FA166721
2mg | 136.00 € | ||
5mg | 167.00 € | ||
10mg | 234.00 € | ||
25mg | 352.00 € | ||
50mg | 548.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Upadacitinib-D2,15N
Controlled ProductCAS:1310726-60-3
Formula:
C17D2H17F3NN5O
Color and Shape:
Neat
Molecular weight:
383.373
Ref: TR-U800077
25mg | 29,658.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Ref: TR-U800075
100mg | Discontinued | Request information |